Post-menopausal womens health is increasingly becoming a critical issue in the United States, especially as the Baby Boomer generation enters retirement age. Probably the most important and most avoidable issue is the growing prevalence of bone-related disorders, such as osteoporosis, among post-menopausal women. The U.S. womens health ingredients market is, and will continue to be, driven by the prevalence of health disorders specific to women and rising health care costs. In this scenario, preventive health care is the best way for consumers to go forward in maintaining a healthy and active lifestyle.
Currently, an estimated 8.2 million American females older than the age of 55 have developed osteoporosis, and more than 1.2 million fracture events occurred in 2012 at an average treatment cost of $11,020. This equates to more than USD$14.0 billion in annual direct health care costs solely associated with treating the fracture and does not take into consideration additional indirect costs including lost productivity, mobility and general quality of life.
As osteoporosis becomes increasingly more prevalent in the United States due to the aging of America, the importance of using key womens health ingredients becomes more apparent as a means to help control the increasing financial burden of osteoporosis. Calcium, vitamin D and magnesium are key dietary supplement options available in the market that have been shown to have a substantiated positive preventive impact on osteoporosis-attributed events.
Read this full article in INSIDER's Menopause Digital Pulse.
Christopher Shanahan is global program manager, food and agriculture practice at Frost & Sullivan .